OncoSec Medical Incorporated

OncoSec Medical Incorporatedverified

ONCS

Price:

$0.2772

Market Cap:

$1.65M

OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in clinical trials collaboration and supply agreement (KEYNOTE-695) and metastatic triple negative breast cancer, which is in Phase II clinical trials (KEYNOTE-...[Read more]

Industry

Biotechnology

IPO Date

2010-04-07

Stock Exchange

NASDAQ

Ticker

ONCS

The Enterprise Value as of December 2024 (TTM) for OncoSec Medical Incorporated (ONCS) is -4472153.00

According to OncoSec Medical Incorporated’s latest financial reports and current stock price. The company's current Enterprise Value is -4472153.00. This represents a change of -127.89% compared to the average of 16.03M of the last 4 quarters.

OncoSec Medical Incorporated (ONCS) Historical Enterprise Value (quarterly & annually)

How has ONCS Enterprise Value performed in the past?

The mean historical Enterprise Value of OncoSec Medical Incorporated over the last ten years is 27.87M. The current -4472153.00 Enterprise Value has changed -1704.58% with respect to the historical average. Over the past ten years (40 quarters), ONCS's Enterprise Value was at its highest in in the January 2021 quarter at 166.40M. The Enterprise Value was at its lowest in in the July 2019 quarter at -1317753.50.

Quarterly (TTM)
Annual

Average

27.87M

Median

30.05M

Minimum

-9335236.82

Maximum

56.92M

OncoSec Medical Incorporated (ONCS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of OncoSec Medical Incorporated Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 469.99%

Maximum Annual Enterprise Value = 56.92M

Minimum Annual Increase = -709.68%

Minimum Annual Enterprise Value = -9335236.82

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202223.13M-30.10%
202133.10M-41.85%
202056.92M-709.68%
2019-9335236.82-120.32%
201845.95M391.40%
20179.35M469.99%
20161.64M-96.35%
201544.98M-2.18%
201445.99M70.34%
201327.00M199.24%

OncoSec Medical Incorporated (ONCS) Average Enterprise Value

How has ONCS Enterprise Value performed in the past?

The current Enterprise Value of OncoSec Medical Incorporated (ONCS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

37.71M

5-year avg

29.95M

10-year avg

27.87M

OncoSec Medical Incorporated (ONCS) Enterprise Value vs. Peers

How is ONCS’s Enterprise Value compared to its peers?

OncoSec Medical Incorporated’s Enterprise Value is less than ZyVersa Therapeutics, Inc. (2.57M), less than Palisade Bio, Inc. (-2953174.00), less than Unicycive Therapeutics, Inc. (38.02M), greater than Apexigen, Inc. (-5121682.00), less than Immix Biopharma, Inc. (41.37M), less than Phio Pharmaceuticals Corp. (0), less than 180 Life Sciences Corp. (-3068516.00), less than Navidea Biopharmaceuticals, Inc. (6.01M), less than First Wave BioPharma, Inc. (-2595051.00), less than Dermata Therapeutics, Inc. (2.80M), less than Revelation Biosciences, Inc. (-3409123.00), less than Panbela Therapeutics, Inc. (-4029924.00), less than ContraFect Corporation (7.92M), less than Quoin Pharmaceuticals, Ltd. (-2858930.00), less than Allarity Therapeutics, Inc. (-667131.00), greater than Kiromic BioPharma, Inc. (-12625909.00), less than Virax Biolabs Group Limited (13.26M), less than Biodexa Pharmaceuticals Plc (4.10M), less than null (775.53M),

Build a custom stock screener for OncoSec Medical Incorporated (ONCS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OncoSec Medical Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OncoSec Medical Incorporated (ONCS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OncoSec Medical Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is OncoSec Medical Incorporated's Enterprise Value?

What is the highest Enterprise Value for OncoSec Medical Incorporated (ONCS)?

What is the 3-year average Enterprise Value for OncoSec Medical Incorporated (ONCS)?

What is the 5-year average Enterprise Value for OncoSec Medical Incorporated (ONCS)?

How does the current Enterprise Value for OncoSec Medical Incorporated (ONCS) compare to its historical average?